Medications are an integral part of care provided to older adults. Many drugs play a positive role in limiting or solving a health problem but monitoring can be complicated due the risk of side effects and comorbidities. According to research from CMS, the use of nine of more medications in elders increases the risk of adverse drug events (2010).
Pharmacogenetics can play an important role in effective use of medications by optimizing drug dose, identifying responders and non-responders to medications, and avoiding adverse events by aligning medications with personal DNA. Pharmacogenetics has been used in acute settings but under-utilized in long-term care. It can be an important tool in fall prevention programs, dementia care, pain management, and anti-psychotic reduction will be a key component for regulatory compliance under the Proposed Rule FY 2017.
This workshop will discuss the implementation of a pharmacogenetics program for improving quality of life, quality of care, reducing medication costs, and personalizing medications and optimizing well-being.
Format: Keynote or workshop intensive session.
This program is perfect for:
- Existing Nurse leaders
- Emerging nurse leaders
- Executive directors
- Non-magers in leadership roles
The audience will leave with: Objectives
- Describe the science of pharmacogenetics and how it can be used for optimizing drug use, identifying responders and non-responders to medications, and avoiding adverse drug events.
- Discuss how specific clinical conditions such as falls, behaviors, pain, and polypharmacy can be improved through the use of pharmacogenetics testing.
- List specific approaches for implementing a pharmacogenetics program, reducing costs, maintaining compliance, and improving the quality of life for older adults.